Infinity Pharmaceuticals Inc (INFI) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Summary

Infinity Pharmaceuticals Inc (Infinity Pharmaceuticals) is a biopharmaceutical company that discovers and develops small molecule therapeutics for the treatment of cancer. The companys pipeline candidate: IPI-549 selectively inhibits PI3K-gamma to reprogram tumor-associated macrophages and transforms immuno-oncology approach. It is evaluating IPI-549 as a monotherapy in Phase 2 for a solid tumor. Infinity Pharmaceuticals is also investigating IPI-549 in Phase 1 for solid tumors, and in Phase 1B for non-small cell lung cancer (NSCLC), melanoma, squamous cell carcinoma of the head and neck (SCCHN), triple negative breast cancer (TNBC), mesothelioma, adrenocortical carcinoma, and myeloid-derived suppressor cells (MDSC). Infinity Pharmaceuticals is headquartered in Cambridge, Massachusetts, the US.

Infinity Pharmaceuticals Inc (INFI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 4
List of Figures 4
Infinity Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Infinity Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Infinity Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Infinity Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Infinity Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Infinity Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Infinity Pharma Exercises Option to Acquire Duvelisib Royalty Rights from Takeda Pharma 10
Partnerships 11
Arcus Biosciences and Infinity Pharma Enter into Clinical Collaboration Agreement 11
Bristol-Myers Squibb Expands Agreement with Infinity Pharma 12
Pharm-Olam International Enters into Agreement with Infinity Pharma 13
Lead Discovery Center Partners with Infinity Pharma 14
Licensing Agreements 15
PellePharm Enters into Licensing Agreement with Infinity Pharma 15
Verastem Enters into Licensing Agreement with Infinity Pharma for Duvelisib 16
FAAH Pharma Enters into Licensing Agreement with Infinity Pharma 18
Equity Offering 19
Infinity Pharma Plans to Raise USD2.5 Million in Public Offering of Shares 19
Infinity Pharmaceuticals to Raise USD50 Million in Offering of Common Stock 21
Infinity Pharma Completes Public Offering Of Common Stock For US$173 Million 22
Infinity Pharma Completes Private Placement Of Shares For US$78.5 Million 24
Infinity Pharma Completes Public Offering Of Common Stock For US$88 Million 25
Infinity Pharmaceuticals Inc - Key Competitors 27
Infinity Pharmaceuticals Inc - Key Employees 28
Infinity Pharmaceuticals Inc - Locations And Subsidiaries 29
Head Office 29
Other Locations & Subsidiaries 29
Recent Developments 30
Financial Announcements 30
May 08, 2018: Infinity Pharmaceuticals Provides Company Update and First Quarter 2018 Financial Results 30
Nov 07, 2017: Infinity Provides Company Update and Reports Third Quarter 2017 Financial Results 32
Aug 03, 2017: Infinity Provides Company Update and Reports Second Quarter 2017 Financial Results 34
May 09, 2017: Infinity Provides Company Reports First Quarter 2017 Financial Results 37
Mar 14, 2017: Infinity Provides Company Update and Reports Fourth Quarter 2016 Financial Results 38
Corporate Communications 40
Mar 08, 2018: Infinity Pharmaceuticals Announces Additions to Board of Directors and Clinical Leadership Team and Establishes Scientific Advisory Board 40
Feb 13, 2017: Infinity Announces Promotion of Jeffery Kutok, M.D., Ph.D. to Chief Scientific Officer 42
Jan 04, 2017: Infinity Announces Organizational Changes 43
Appendix 45
Methodology 45
About GlobalData 45
Contact Us 45
Disclaimer 45

List Of Tables

List of Tables
Infinity Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Infinity Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Infinity Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Infinity Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Infinity Pharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Infinity Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Infinity Pharma Exercises Option to Acquire Duvelisib Royalty Rights from Takeda Pharma 10
Arcus Biosciences and Infinity Pharma Enter into Clinical Collaboration Agreement 11
Bristol-Myers Squibb Expands Agreement with Infinity Pharma 12
Pharm-Olam International Enters into Agreement with Infinity Pharma 13
Lead Discovery Center Partners with Infinity Pharma 14
PellePharm Enters into Licensing Agreement with Infinity Pharma 15
Verastem Enters into Licensing Agreement with Infinity Pharma for Duvelisib 16
FAAH Pharma Enters into Licensing Agreement with Infinity Pharma 18
Infinity Pharma Plans to Raise USD2.5 Million in Public Offering of Shares 19
Infinity Pharmaceuticals to Raise USD50 Million in Offering of Common Stock 21
Infinity Pharma Completes Public Offering Of Common Stock For US$173 Million 22
Infinity Pharma Completes Private Placement Of Shares For US$78.5 Million 24
Infinity Pharma Completes Public Offering Of Common Stock For US$88 Million 25
Infinity Pharmaceuticals Inc, Key Competitors 27
Infinity Pharmaceuticals Inc, Key Employees 28
Infinity Pharmaceuticals Inc, Subsidiaries 29

List Of Figures

List of Figures
Infinity Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Infinity Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Infinity Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Infinity Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Infinity Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Infinity Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Infinity Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Infinity Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Infinity Energy Resources Inc (IFNY) - Oil and Gas - Deals and Alliances Profile

Infinity Energy Resources Inc (Infinity Energy) is an oil and gas company that offers exploration and development of crude oil resources. The company operates oil and gas concessions located at

USD 250 View Report

Infinity Pharmaceuticals Inc (INFI) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Infinity Pharmaceuticals Inc (Infinity Pharmaceuticals) is a biopharmaceutical company that discovers and develops small molecule therapeutics for the treatment of cancer. The companys pipeline candidate: IPI-549 selectively inhibits PI3K-gamma to

USD 250 View Report

Constellation Pharmaceuticals Inc (CNST) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Constellation Pharmaceuticals Inc (Constellation) is a clinical biopharmaceutical company that focuses to develop novel therapeutics for the treatment of serious unmet medical needs in patients with cancers associated with abnormal

USD 250 View Report

Cannabics Pharmaceuticals Inc (CNBX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Cannabics Pharmaceuticals Inc (Cannabics Pharmaceuticals), formerly Thrust Energy Corp, is a drug development company that develops cannabinoid-based therapies for cancer. The company develops High Content Screening (HCS) Platform, an automated

USD 250 View Report

Your are not allow to send sample request

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available